Lung Cancer

Lung Cancer in the Time of COVID-19: Challenges and Solutions

By

Tori Rodriguez, MA, LPC, AHC

Publish Date August 25, 2020

In the midst of the COVID-19 pandemic, patients with lung cancer face an increased risk of disease progression, reduced survival, and worse quality of life associated with delayed treatment.

Prior PD-1 Blockade Did Not Appear to Affect COVID-19 Severity in Lung Cancer

By

Victoria Forster, PhD

Publish Date July 3, 2020

There have been some concerns that the immunomodulatory effect of PD-1 blockade may influence the response of patients with cancer to COVID-19.

Decline in Lung Cancer Mortality Affects Decreases in Overall Cancer Deaths

By

Britt Gambino

Publish Date January 14, 2020

Reductions in lung cancer mortality are driving the steady decline in overall cancer deaths.

Lung Cancer Tied to Most Potential Years of Life Lost

Potential years of life lost per death highest for deaths due to cancers of testis, bones/joints, other endocrine sites

Osimertinib Gets Priority Review for Early-Stage EGFR-Mutated NSCLC

The sNDA is supported by data from the phase 3 ADAURA trial that assessed osimertinib vs placebo in 682 patients with early-stage EGFRm NSCLC after complete tumor resection with or without adjuvant chemotherapy.

Common Medications May Be Associated With Lower Lung Cancer Mortality

Use of aspirin, metformin, and statins is associated with a lower risk for lung cancer mortality.

Patient Access to Lung Cancer Treatment Guidelines May Improve Quality of Care

Use of cancer treatment guidelines is not in conflict with shared decision-making; therefore, increasing patients’ access to guidelines may improve the quality of oncologic care.

Simple Tool Increases Adherence to Planned On-Treatment Clinic Visits for Lung Cancer Radiotherapy

A single-institution, retrospective study determined that having a tangible item improved patient adherence to radiotherapy on-treatment clinic visits.